FDA Flouted Law To Undercut $375K Drug, Suit Says
By Jeff Overley · June 12, 2019, 4:13 PM EDT
The U.S. Food and Drug Administration unlawfully approved a lower-cost version of a $375,000 per year drug for a rare autoimmune disease because of concerns about affordability, according to a lawsuit...
To view the full article, register now.